Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
S-309309 in Obese Adults
NCT05925114Phase 2Completed
- Sponsor
- Shionogi & Co., Ltd.
- Start
- Jun 2023
- Primary completion
- Apr 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of S-309309 in obesity, sponsored by Shionogi & Co., Ltd.. Started Jun 2023; status: completed.
02
Drugs
S-309309
03
Conditions
obesity
Beyond the preview
Go deeper on NCT05925114.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05925114.